FDA approves landmark pancreatic cancer drug that's shown to improve survival

Дата публикации: 26-08-2026 21:53:57

WASHINGTON (AP) — The Food and Drug Administration on Wednesday approved a groundbreaking new drug for advanced pancreatic cancer, offering U.S. patients a more effective treatment against one of the deadliest types of cancer. FDA officials gave expedited approval to the first-of-a-kind pill, called daraxonrasib, which blocks a mutated protein that fuels tumor growth in [...]

Схожие новости

#	Наименование новости	Тональность	Информативность	Дата публикации
1	FDA gives expedited approval to new groundbreaking pancreatic cancer drug	0	6.49	26-08-2026
2	FDA approves groundbreaking new pancreatic cancer drug	0	7.77	26-08-2026
3	Scientists finally crack an “undruggable” pancreatic cancer target and nearly double survival	0	7.13	04-06-2026
4	Tumore al pancreas: primo sì dell'Europa al farmaco che raddoppia la sopravvivenza	0	6.17	17-10-2026
5	"FDA" توافق على دواء جديد لعلاج سرطان البنكرياس	0	6.87	27-08-2026
6	الغذاء والدواء الأميركية توافق على دواء لسرطان البنكرياس	0	6.05	27-08-2026
7	حبوب جديدة تضاعف متوسط البقاء في سرطان البنكرياس	0	8.82	26-08-2026
8	New Targeted Therapy Shows Promising Early Results in Advanced Pancreatic Cancer	5	7	02-07-2026
9	New targeted therapy shows promising early results in advanced pancreatic cancer	2	7	05-07-2026
10	FDA Approves Daraxonrasib for Metastatic Pancreatic Adenocarcinoma	0	13.78	19-10-2026

Классификация: . Схожих патентов: 0. Схожих новостей: 10. Тональность: 0. Информативность: 7.9. Источник: www.myhighplains.com.